Does Novo Nordisk’s (CPSE:NOVO B) Alzheimer’s Setback Challenge Its Long-Term Diversification Ambitions?
On November 24, 2025, Novo Nordisk announced top-line results from its phase 3 evoke and evoke+ trials, revealing…
What we know about the Alzheimer’s drug Health Canada approved
Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer’s disease, raising questions about its effectiveness…
New research reveals simple activity to reduce dementia risk: ‘Improved health outcomes’
A new study suggests that a simple daily activity could do more than save money or cut down…
Scientists Just Discovered a Whole New Type of Connection Between Neurons
Super-resolution microscopes have revealed a whole new type of connection between neurons in mouse and human brains. In…
Immune-informed brain aging research offers new treatment possibilities, speakers say | MIT News
Understanding how interactions between the central nervous system and the immune system contribute to problems of aging, including…
Study lists daily habits that can slow dementia
The same lifestyle changes found effective in reducing heart disease risk, such as exercise, healthy eating, and social…